Table 1.
Sociographic, patient, tumor, and treatment characteristics
| Patients (n = 43) | ||
|---|---|---|
| Socio-demographic characteristics (at the time of QoL assessment) | ||
| Age, years (median, IQR) | 63 | 56–75 |
| Marital status-n, % | ||
| Single | 2 | 5 |
| Married | 22 | 51 |
| Widowed | 12 | 28 |
| Separated | 7 | 16 |
| Educational status-n, % | ||
| None | 3 | 7 |
| Primary | 20 | 47 |
| Secondary | 13 | 30 |
| Tertiary | 7 | 16 |
| Patient characteristics (at the time of QoL assessment) | ||
| Body mass index, kg/m2 (median, IQR) | 26 | 20–38 |
| American Society of Anesthesiologists (ASA) score-n, % | ||
| 1 | 5 | 12 |
| 2 | 26 | 60 |
| 3 | 12 | 28 |
| Comorbidities or risk factors-n, % | ||
| Hypertension | 20 | 47 |
| Diabetes mellitus | 6 | 14 |
| Heavy smoking | 1 | 5 |
| Dementia or depression | 2 | 5 |
| Previous malignancies | 4 | 9 |
| None | 14 | 33 |
| Tumor characteristics | ||
| Histological tumor type-n, % | ||
| Squamous cell | 42 | 98 |
| Basal cell | 1 | 2 |
| Tumor size in mm-median, IQR | ||
| Maximum diameter | 15 | 10–34 |
| Infiltration depth | 5 | 3–12 |
| Pathological tumor stage-n, % | ||
| 1a | 5 | 12 |
| 1b | 33 | 77 |
| 2 | 5 | 12 |
| Ontogenetic tumor stage (oT)- n, % | ||
| 1 | 28 | 65 |
| 2 | 9 | 21 |
| 3a/3b | 6 | 14 |
| Pathological node stage-n, % | ||
| 0 | 33 | 77 |
| 1a | 2 | 5 |
| 1b | 3 | 7 |
| 2b | 1 | 2 |
| 2c | 4 | 9 |
| International Federation of Gynecology and Obstetrics (FIGO) stage-n, % | ||
| IA | 5 | 12 |
| IB | 28 | 65 |
| II | 1 | 2 |
| IIIA | 4 | 9 |
| IIIB | 1 | 2 |
| IIIC | 4 | 9 |
| Treatment characteristics | ||
| Type of lymph-node dissection-n, % | ||
| None | 5 | 12 |
| Sentinel | 7 | 16 |
| First-line inguinal | 9 | 21 |
| Total inguinala | 22 | 51 |
| Type of anatomic reconstruction-n, % | ||
| None (direct closure) | 4 | 9 |
| Random flaps | 24 | 56 |
| Axial pattern flaps | 15 | 35 |
| Selected complications/sequelae | ||
| Postoperative inguinal wound infection leading to wound breakdown, stratified for nodal status-n, % | ||
| pN0, n = 33 | 4 | 12.2 |
| pN1, n = 10 | 4 | 40 |
| Occurrence of postoperative lymphedema according to LNE typeb-n, % | ||
| No LNE | 1 | 20 |
| Sentinel LNE | 2 | 28.6 |
| First-line inguinal LNE | 4 | 44.4 |
| Total inguinal LNE | 10 | 45.5 |
IQR: interquartile range
aincluding two patients with distal pelvic LND and one patient with inguinopelvic (lacunar) LND
bthe number of patients receiving each LNE type is given above (treatment characteristics section of Table 1). See also Fig. S3A